Life Summary
Lee Gi Soo is the CEO and President of Yungjin Pharm.

He was born in July 1966.

Lee earned a Ph.D. in Cell Genetics from Kumamoto University in Japan.

After working at Hanil Pharmaceutical and CJ CheilJedang, he served as Head of International Business at Yungjin Pharm in 2012 and as an executive in Global Business at Chong Kun Dang in 2017.

In March 2022, Lee returned as CEO of Yungjin Pharm. He was brought in as a “relief pitcher” to overcome the company’s sluggish performance during the COVID-19 pandemic.

Lee successfully turned the company around in just two years by increasing the proportion of Yungjin Pharm's in-house products and focusing on management efficiency.

He is actively driving aggressive investments in research and development as well as fostering open innovation. There is growing interest in whether he will be reappointed when his term expires in February 2025.

#YungjinPharm #LeeGiSoo #CEO #pharmaceuticals #COVID19 #turnaroundsuccess #R&D #openinnovation #managementefficiency #ChongKunDang